Fresenius SE & Co KGaA (FRE.DE) stock: key figures, P/E, revenue and dividend

Health Care · Germany · ISIN DE0005785604

Price
43.56 EUR
Market cap
24.53 bn EUR
P/E (2025)
19.41
P/S (2025)
1.07
Dividend yield
2.41 %
Net margin
5.53 %
Return on equity (ROE)
–
Return on assets (ROA)
3.05 %

Fresenius SE & Co KGaA financials

Fiscal year20242025
Revenue21.83 bn EUR22.87 bn EUR
Gross profit5.38 bn EUR5.69 bn EUR
Operating income2.07 bn EUR2.30 bn EUR
EBIT1.84 bn EUR2.50 bn EUR
Net income471.00 m EUR1.26 bn EUR
Diluted EPS – continuing operations0.84 EUR2.24 EUR

Full history since 1996, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.

Fresenius SE & Co KGaA stock (FRE.DE): P/E, revenue, dividend | finmetric